42 results on '"Aiman Alzetani"'
Search Results
2. Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2
- Author
-
Joseph A. Bell, Elizabeth R. Davies, Christopher J. Brereton, Milica Vukmirovic, James J.W. Roberts, Kerry Lunn, Leanne Wickens, Franco Conforti, Robert A. Ridley, Jessica Ceccato, Lucy N. Sayer, David A. Johnston, Andres F. Vallejo, Aiman Alzetani, Sanjay Jogai, Ben G. Marshall, Aurelie Fabre, Luca Richeldi, Phillip D. Monk, Paul Skipp, Naftali Kaminski, Emily Offer, Yihua Wang, Donna E. Davies, and Mark G. Jones
- Subjects
fibrosis ,spatial transcriptomics ,disease-relevant biomimetic models ,LOXL2 ,target engagement ,Medicine (General) ,R5-920 - Abstract
Summary: Matrix stiffening by lysyl oxidase-like 2 (LOXL2)-mediated collagen cross-linking is proposed as a core feedforward mechanism that promotes fibrogenesis. Failure in clinical trials of simtuzumab (the humanized version of AB0023, a monoclonal antibody against human LOXL2) suggested that targeting LOXL2 may not have disease relevance; however, target engagement was not directly evaluated. We compare the spatial transcriptome of active human lung fibrogenesis sites with different human cell culture models to identify a disease-relevant model. Within the selected model, we then evaluate AB0023, identifying that it does not inhibit collagen cross-linking or reduce tissue stiffness, nor does it inhibit LOXL2 catalytic activity. In contrast, it does potently inhibit angiogenesis consistent with an alternative, non-enzymatic mechanism of action. Thus, AB0023 is anti-angiogenic but does not inhibit LOXL2 catalytic activity, collagen cross-linking, or tissue stiffening. These findings have implications for the interpretation of the lack of efficacy of simtuzumab in clinical trials of fibrotic diseases.
- Published
- 2024
- Full Text
- View/download PDF
3. LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis
- Author
-
Zijian Xu, Elizabeth R. Davies, Liudi Yao, Yilu Zhou, Juanjuan Li, Aiman Alzetani, Ben G. Marshall, David Hancock, Tim Wallis, Julian Downward, Rob M. Ewing, Donna E. Davies, Mark G. Jones, and Yihua Wang
- Subjects
CAB39L ,Crosstalk ,EMT ,LKB1 ,Pulmonary fibrosis ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
The factors that determine fibrosis progression or normal tissue repair are largely unknown. We previously demonstrated that autophagy inhibition-mediated epithelial–mesenchymal transition (EMT) in human alveolar epithelial type II (ATII) cells augments local myofibroblast differentiation in pulmonary fibrosis by paracrine signaling. Here, we report that liver kinase B1 (LKB1) inactivation in ATII cells inhibits autophagy and induces EMT as a consequence. In IPF lungs, this is caused by the down-regulation of CAB39L, a key subunit within the LKB1 complex. 3D co-cultures of ATII cells and MRC5 lung fibroblasts coupled with RNA sequencing (RNA-seq) confirmed that paracrine signaling between LKB1-depleted ATII cells and fibroblasts augmented myofibroblast differentiation. Together, these data suggest that reduced autophagy caused by LKB1 inhibition can induce EMT in ATII cells and contribute to fibrosis via aberrant epithelial–fibroblast crosstalk.
- Published
- 2024
- Full Text
- View/download PDF
4. Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer
- Author
-
Christopher J. Hanley, Sara Waise, Matthew J. Ellis, Maria A. Lopez, Wai Y. Pun, Julian Taylor, Rachel Parker, Lucy M. Kimbley, Serena J. Chee, Emily C. Shaw, Jonathan West, Aiman Alzetani, Edwin Woo, Christian H. Ottensmeier, Matthew J. J. Rose-Zerilli, and Gareth J. Thomas
- Subjects
Science - Abstract
Fibroblast heterogeneity is a prominent but poorly understood feature of solid tumours. Here three major fibroblast subpopulations in non-small cell lung cancer are identified and characterised through single cell RNA-sequencing, multiplexed immunohistochemistry and digital cytometry.
- Published
- 2023
- Full Text
- View/download PDF
5. Three Dimensional Modelling in the Optimisation of Chest Wall Resection and Reconstruction Following Metastatic Breast Cancer
- Author
-
Hanad Ahmed, Mansoor Khan, and Aiman Alzetani
- Subjects
bone metastasis ,breast imaging ,metastasis ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Medicine - Abstract
Two-dimensional computed tomography scans no longer offer the level of detail that many surgeons desire for more accurate and precise surgical intervention. Computed tomography image reconstruction into three dimensional (3D) virtual models with interactive capability is providing an enhanced understanding of the patient’s anatomy and pathology allowing the surgeon to create tailored intraoperative plans, minimizing complications and maximizing the intended therapeutic outcome. In this case report we demonstrate the use of 3D image reconstruction software in the management of a 36-year-old female with metastatic breast cancer affecting the chest wall.
- Published
- 2022
- Full Text
- View/download PDF
6. Chest Wall Silicone Granuloma Following Ruptured Silicone Breast Implant Causes Giant Chest Wall Abscess and Osteomyelitis: The First Report
- Author
-
Hanad Ahmed, Alessandro Tamburrini, Mansoor Khan, and Aiman Alzetani
- Subjects
silicone breast implant ,rupture ,granuloma ,chest wall ,cardiothoracic ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Medicine - Abstract
Silicone breast implant ruptures have been widely reported in the literature. Granuloma formation is a known complication of such ruptures with reported sites including the axillae, limbs, chest wall muscles, and internal organs, such as the lungs and the liver. To the best of our knowledge, there are no reported cases of a silicone granuloma causing osteomyelitis of the sternum and multiple ribs in the absence of infection. We therefore report on the case of an 81-year-old patient who presented with an anterior chest wall discharging sinus tract on the background of a ruptured silicone breast implant. We raise awareness about the potentially devastating complications resulting from a ruptured silicone implant with relevance to cardiothoracic practice.
- Published
- 2021
- Full Text
- View/download PDF
7. Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
- Author
-
Christopher J Brereton, Liudi Yao, Elizabeth R Davies, Yilu Zhou, Milica Vukmirovic, Joseph A Bell, Siyuan Wang, Robert A Ridley, Lareb SN Dean, Orestis G Andriotis, Franco Conforti, Lennart Brewitz, Soran Mohammed, Timothy Wallis, Ali Tavassoli, Rob M Ewing, Aiman Alzetani, Benjamin G Marshall, Sophie V Fletcher, Philipp J Thurner, Aurelie Fabre, Naftali Kaminski, Luca Richeldi, Atul Bhaskar, Christopher J Schofield, Matthew Loxham, Donna E Davies, Yihua Wang, and Mark G Jones
- Subjects
fibrosis ,Collagen ,Lung ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Extracellular matrix (ECM) stiffening with downstream activation of mechanosensitive pathways is strongly implicated in fibrosis. We previously reported that altered collagen nanoarchitecture is a key determinant of pathogenetic ECM structure-function in human fibrosis (Jones et al., 2018). Here, through human tissue, bioinformatic and ex vivo studies we provide evidence that hypoxia-inducible factor (HIF) pathway activation is a critical pathway for this process regardless of the oxygen status (pseudohypoxia). Whilst TGFβ increased the rate of fibrillar collagen synthesis, HIF pathway activation was required to dysregulate post-translational modification of fibrillar collagen, promoting pyridinoline cross-linking, altering collagen nanostructure, and increasing tissue stiffness. In vitro, knockdown of Factor Inhibiting HIF (FIH), which modulates HIF activity, or oxidative stress caused pseudohypoxic HIF activation in the normal fibroblasts. By contrast, endogenous FIH activity was reduced in fibroblasts from patients with lung fibrosis in association with significantly increased normoxic HIF pathway activation. In human lung fibrosis tissue, HIF-mediated signalling was increased at sites of active fibrogenesis whilst subpopulations of human lung fibrosis mesenchymal cells had increases in both HIF and oxidative stress scores. Our data demonstrate that oxidative stress can drive pseudohypoxic HIF pathway activation which is a critical regulator of pathogenetic collagen structure-function in fibrosis.
- Published
- 2022
- Full Text
- View/download PDF
8. Immunofluorescence-guided segmentation of three-dimensional features in micro-computed tomography datasets of human lung tissue
- Author
-
Matthew J. Lawson, Orestis L. Katsamenis, David Chatelet, Aiman Alzetani, Oliver Larkin, Ian Haig, Peter Lackie, Jane Warner, and Philipp Schneider
- Subjects
correlative imaging ,histology ,blood vessel networks ,SIFT ,registration ,warping ,Science - Abstract
Micro-computed tomography (µCT) provides non-destructive three-dimensional (3D) imaging of soft tissue microstructures. Specific features in µCT images can be identified using correlated two-dimensional (2D) histology images allowing manual segmentation. However, this is very time-consuming and requires specialist knowledge of the tissue and imaging modalities involved. Using a custom-designed µCT system optimized for imaging unstained formalin-fixed paraffin-embedded soft tissues, we imaged human lung tissue at isotropic voxel sizes less than 10 µm. Tissue sections were stained with haematoxylin and eosin or cytokeratin 18 in columnar airway epithelial cells using immunofluorescence (IF), as an exemplar of this workflow. Novel utilization of tissue autofluorescence allowed automatic alignment of 2D microscopy images to the 3D µCT data using scripted co-registration and automated image warping algorithms. Warped IF images, which were accurately aligned with the µCT datasets, allowed 3D segmentation of immunoreactive tissue microstructures in the human lung. Blood vessels were segmented semi-automatically using the co-registered µCT datasets. Correlating 2D IF and 3D µCT data enables accurate identification, localization and segmentation of features in fixed soft lung tissue. Our novel correlative imaging workflow provides faster and more automated 3D segmentation of µCT datasets. This is applicable to the huge range of formalin-fixed paraffin-embedded tissues held in biobanks and archives.
- Published
- 2021
- Full Text
- View/download PDF
9. Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study)
- Author
-
Chris A Rogers, Lucy Culliford, Maria Pufulete, Sarah Baos, Mark Edwards, Sarah Wordsworth, Elizabeth A Stokes, Holly Mckeon, Gianluca Casali, Aiman Alzetani, Reyad Abbadi, Nilesh Chauhan, Laura Collett, Samantha E de Jesus, Nicholas Goddard, Jennifer Lamb, Mat Molyneux, and Ben Gibbison
- Subjects
Medicine - Abstract
Introduction Gabapentin is an antiepileptic drug currently licensed to treat epilepsy and neuropathic pain but has been used off-label to treat acute postoperative pain. The GAP study will compare the effectiveness, cost-effectiveness and safety of gabapentin as an adjunct to standard multimodal analgesia versus placebo for the management of pain after major surgery.Methods and analysis The GAP study is a multicentre, double-blind, randomised controlled trial in patients aged 18 years and over, undergoing different types of major surgery (cardiac, thoracic or abdominal). Patients will be randomised in a 1:1 ratio to receive either gabapentin (600 mg just before surgery and 600 mg/day for 2 days after surgery) or placebo in addition to usual pain management for each type of surgery. Patients will be followed up daily until hospital discharge and then at 4 weeks and 4 months after surgery. The primary outcome is length of hospital stay following surgery. Secondary outcomes include pain, total opioid use, adverse health events, health related quality of life and costs.Ethics and dissemination This study has been approved by the Research Ethics Committee . Findings will be shared with participating hospitals and disseminated to the academic community through peer-reviewed publications and presentation at national and international meetings. Patients will be informed of the results through patient organisations and participant newsletters.Trial registration number ISRCTN63614165.
- Published
- 2020
- Full Text
- View/download PDF
10. M1hot tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer
- Author
-
Eva M Garrido-Martin, Toby W P Mellows, James Clarke, Anusha-Preethi Ganesan, Oliver Wood, Angelica Cazaly, Gregory Seumois, Serena J Chee, Aiman Alzetani, Emma V King, Gareth Thomas, Peter S Friedmann, Pandurangan Vijayanand, and Tilman Sanchez-Elsner
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background The role of tumor-associated macrophages (TAMs) in determining the outcome between the antitumor effects of the adaptive immune system and the tumor’s anti-immunity stratagems, is controversial. Macrophages modulate their activities and phenotypes by integration of signals in the tumor microenvironment. Depending on how macrophages are activated, they may adopt so-called M1-like, antitumor or M2-like, protumor profiles. In many solid tumors, a dominance of M2-like macrophages is associated with poor outcomes but in some tumor types, strong M1-like profiles are linked to better outcomes. We aimed to investigate the interrelationship of these TAM populations to establish how they modulate the efficacy of the adaptive immune system in early lung cancer.Methods Macrophages from matched lung (non-tumor-associated macrophages (NTAMs)) and tumor samples (TAMs) from resected lung cancers were assessed by bulk and single-cell transcriptomic analysis. Protein expression of genes characteristic of M1-like (chemokine (C-X-C motif) ligand 9) or M2-like (matrix metallopeptidase 12) functions was confirmed by confocal microscopy. Immunohistochemistry related the distribution of TAM transcriptomic signatures to density of CD8+ tissue-resident memory T cells (TRM) in tumors and survival data from an independent cohort of 393 patients with lung cancer.Results TAMs have significantly different transcriptomic profiles from NTAMs with >1000 differentially expressed genes. TAMs displayed a strong M2-like signature with no significant variation between patients. However, single-cell RNA-sequencing supported by immuno-stained cells revealed that additionally, in 25% of patients the M2-like TAMs also co-expressed a strong/hot M1-like signature (M1hot). Importantly, there was a strong association between the density of M1hot TAMs and TRM cells in tumors that was in turn linked to better survival. Our data suggest a mechanism by which M1hot TAMs may recruit TRM cells via CXCL9 expression and sustain them by making available more of the essential fatty acids on which TRM depend.Conclusions We showed that in early lung cancer, expression of M1-like and M2-like gene signatures are not mutually exclusive since the same TAMs can simultaneously display both gene-expression profiles. The presence of M1hot TAMs was associated with a strong TRM tumor-infiltrate and better outcomes. Thus, therapeutic approaches to re-program TAMs to an M1hot phenotype are likely to augment the adaptive antitumor responses.
- Published
- 2020
- Full Text
- View/download PDF
11. Delayed post-traumatic presentation of severe sternal osteomyelitis: A strong multidisciplinary effort and a novel reconstruction technique for a challenging case
- Author
-
Alessandro Tamburrini, Hanad Ahmed, Thomas Talbot, Oliver Harrison, Mansoor Khan, Simon Tilley, and Aiman Alzetani
- Subjects
Sternal osteomyelitis ,Chest wall trauma ,Chest wall reconstruction ,Surgery ,RD1-811 - Abstract
Sternal osteomyelitis is a morbid and challenging condition, which can rarely occur after trauma, with no established consensus over best therapeutic options. In this case, a 47-year-old man with history of intravenous drug use presented 11 weeks after a minor blunt chest trauma with a severe necrotizing osteomyelitis involving sternum, muscles, fascia and subcutaneous tissue and positive blood cultures for Methicillin Sensitive Staphylococcus aureus. Alongside tailored antibiotic therapy, extensive surgical debridement was performed, leaving a full thickness 3 × 4 cm sternal defect and a large skin defect. After 4 weeks of antibiotics and Vacuum-Assisted-Closure pump, a novel reconstruction technique was utilized, with full collaborations of thoracic surgeons, orthopaedic surgeons and plastic surgeons. An autologous tricortical iliac crest bone graft was harvested and shaped to fit the full-thickness sternal defect, while two titanium sigmoid-shaped clavicle plates were used for internal fixation of the autograft. The large skin defect was covered with a pedicled myocutaneous latissimus dorsi flap. Integrity and stability of the chest wall was fully restored, and infection was completely eradicated. No complications occurred and the patient was well at the 18 months follow-up. To the best of our knowledge, this is the first report on autologous iliac crest bone graft in the treatment of sternal osteomyelitis. In this case, it proved to be a viable therapeutic option, providing good long-term clinical and cosmetic results.
- Published
- 2020
- Full Text
- View/download PDF
12. Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
- Author
-
Mark G Jones, Orestis G Andriotis, James JW Roberts, Kerry Lunn, Victoria J Tear, Lucy Cao, Kjetil Ask, David E Smart, Alessandra Bonfanti, Peter Johnson, Aiman Alzetani, Franco Conforti, Regan Doherty, Chester Y Lai, Benjamin Johnson, Konstantinos N Bourdakos, Sophie V Fletcher, Ben G Marshall, Sanjay Jogai, Christopher J Brereton, Serena J Chee, Christian H Ottensmeier, Patricia Sime, Jack Gauldie, Martin Kolb, Sumeet Mahajan, Aurelie Fabre, Atul Bhaskar, Wolfgang Jarolimek, Luca Richeldi, Katherine MA O'Reilly, Phillip D Monk, Philipp J Thurner, and Donna E Davies
- Subjects
fibrosis ,extracellular matrix ,biomechanics ,collagen ,lung ,lysyl oxidase ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Matrix stiffening with downstream activation of mechanosensitive pathways is strongly implicated in progressive fibrosis; however, pathologic changes in extracellular matrix (ECM) that initiate mechano-homeostasis dysregulation are not defined in human disease. By integrated multiscale biomechanical and biological analyses of idiopathic pulmonary fibrosis lung tissue, we identify that increased tissue stiffness is a function of dysregulated post-translational collagen cross-linking rather than any collagen concentration increase whilst at the nanometre-scale collagen fibrils are structurally and functionally abnormal with increased stiffness, reduced swelling ratio, and reduced diameter. In ex vivo and animal models of lung fibrosis, dual inhibition of lysyl oxidase-like (LOXL) 2 and LOXL3 was sufficient to normalise collagen fibrillogenesis, reduce tissue stiffness, and improve lung function in vivo. Thus, in human fibrosis, altered collagen architecture is a key determinant of abnormal ECM structure-function, and inhibition of pyridinoline cross-linking can maintain mechano-homeostasis to limit the self-sustaining effects of ECM on progressive fibrosis.
- Published
- 2018
- Full Text
- View/download PDF
13. Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019
- Author
-
Hassan Kattach, Lukacs Veres, Abdul Badran, Hanad Ahmed, Aiman Alzetani, and Alessandro Tamburrini
- Subjects
Pulmonary and Respiratory Medicine ,ARDS ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,viruses ,fungi ,virus diseases ,medicine.disease ,humanities ,respiratory tract diseases ,Surgery ,law.invention ,Pneumonia ,Pneumothorax ,law ,Fraction of inspired oxygen ,Ventilation (architecture) ,medicine ,Persistent air leak ,Cardiology and Cardiovascular Medicine ,business ,Positive end-expiratory pressure - Abstract
Pneumothorax and persistent air leak (PAL) are documented complications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Patients that fall in this category are often poor candidates for invasive thoracic surgical intervention. Endobronchial valves offer an effective and less invasive treatment option and can successfully treat PAL and support the weaning of patients with SARS-CoV-2 pneumonia off ventilation.
- Published
- 2022
- Full Text
- View/download PDF
14. Spatially resolved deconvolution of the fibrotic niche in lung fibrosis
- Author
-
Michael Eyres, Joseph A. Bell, Elizabeth R. Davies, Aurelie Fabre, Aiman Alzetani, Sanjay Jogai, Ben G. Marshall, David A. Johnston, Zijian Xu, Sophie V. Fletcher, Yihua Wang, Gayle Marshall, Donna E. Davies, Emily Offer, and Mark G. Jones
- Subjects
Alveolar Epithelial Cells ,Pulmonary Fibrosis ,Humans ,Fibrosis ,Lung ,General Biochemistry, Genetics and Molecular Biology ,Signal Transduction - Abstract
A defining pathological feature of human lung fibrosis is localized tissue heterogeneity, which challenges the interpretation of transcriptomic studies that typically lose spatial information. Here we investigate spatial gene expression in diagnostic tissue using digital profiling technology. We identify distinct, region-specific gene expression signatures as well as shared gene signatures. By integration with single-cell data, we spatially map the cellular composition within and distant from the fibrotic niche, demonstrating discrete changes in homeostatic and pathologic cell populations even in morphologically preserved lung, while through ligand-receptor analysis, we investigate cellular cross-talk within the fibrotic niche. We confirm findings through bioinformatic, tissue, and in vitro analyses, identifying that loss of NFKB inhibitor zeta in alveolar epithelial cells dysregulates the TGFβ/IL-6 signaling axis, which may impair homeostatic responses to environmental stress. Thus, spatially resolved deconvolution advances understanding of cell composition and microenvironment in human lung fibrogenesis.
- Published
- 2022
15. Image-guided combined ablation and resection in thoracic surgery for the treatment of multiple pulmonary metastases: A preliminary case series
- Author
-
Oliver J. Harrison, Aiman Alzetani, Sajiram Sarvananthan, Alessandro Tamburrini, and Charles Peebles
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Percutaneous ,wedge resection ,image-guided surgery ,Radiofrequency ablation ,medicine.medical_treatment ,iCART, image-guided combined ablation and resection in thoracic surgery ,law.invention ,law ,medicine ,iVATS, image-guided video-assisted thoracoscopic surgery ,pulmonary metastasis ,RFA, radiofrequency ablation ,business.industry ,Microwave ablation ,metastatectomy ,hybrid surgery ,pulmonary nodule ,Ablation ,medicine.disease ,Image-guided surgery ,GGO, ground-glass opacity ,pMWA, percutaneous microwave ablation ,Pneumothorax ,Thoracic: Lung Cancer: Evolving Technology ,microwave ablation ,Surgery ,Radiology ,business ,Lung cancer screening ,Wedge resection (lung) - Abstract
Objectives To demonstrate the feasibility and preliminary outcomes of a novel hybrid technique combining percutaneous microwave ablation and wire-assisted wedge resection for patients with multiple pulmonary metastases using intraoperative imaging. Methods We describe our technique and present a retrospective case series of 4 patients undergoing iCART at our institution between August 2018 and January 2020. Procedures were performed in a hybrid operating suite using the ARTIS Pheno cone beam computerized tomography scanner (Siemens Healthineers, Erlangen, German). Patient information included past history of malignancy as well as lesion size, depth, location, and histology result. Surgical complications and length of stay were also recorded. Results Five procedures were performed on 4 patients during the study period. One patient underwent bilateral procedures 4 weeks apart. All patients underwent at least 1 ablation and 1 wedge resection during the combined procedure. Patient ages ranged from 40 to 66 years and the majority (75%) were men. All had a past history of cancer. Lesions were treated in every lobe. Size and depth ranged from 6 to 24 mm and 21 to 33 mm, respectively, for ablated nodules and 5 to 27 mm and 0 to 22 mm, respectively, for the wedge resected nodules. Three procedures were completed uniportal and operative time ranged from 51 to 210 minutes. All cases sustained, Graphical abstract
- Published
- 2021
16. Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
- Author
-
Liudi Yao, Christopher J Brereton, Elizabeth R Davies, Yilu Zhou, Milica Vukmirovic, Joseph A Bell, Siyuan Wang, Robert A Ridley, Lareb SN Dean, Orestis G Andriotis, Franco Conforti, Lennart Brewitz, Soran Mohammed, Timothy Wallis, Ali Tavassoli, Rob M Ewing, Aiman Alzetani, Benjamin G Marshall, Sophie V Fletcher, Philipp J Thurner, Aurelie Fabre, Naftali Kaminski, Luca Richeldi, Atul Bhaskar, Christopher J Schofield, Matthew Loxham, Donna E Davies, Yihua Wang, and Mark G Jones
- Subjects
Cultured ,General Immunology and Microbiology ,Cells ,Pulmonary Fibrosis ,General Neuroscience ,fibrosis ,Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO ,General Medicine ,Fibroblasts ,General Biochemistry, Genetics and Molecular Biology ,Mixed Function Oxygenases ,Repressor Proteins ,Oxidative Stress ,Gene Expression Regulation ,Transforming Growth Factor beta ,cell biology ,Humans ,human ,Collagen ,Hypoxia-Inducible Factor 1 ,Lung ,Biomarkers ,Cells, Cultured - Abstract
Extracellular matrix (ECM) stiffening with downstream activation of mechanosensitive pathways is strongly implicated in fibrosis. We previously reported that altered collagen nanoarchitecture is a key determinant of pathogenetic ECM structure-function in human fibrosis (Jones et al., 2018). Here, through human tissue, bioinformatic and ex vivo studies we provide evidence that hypoxia-inducible factor (HIF) pathway activation is a critical pathway for this process regardless of the oxygen status (pseudohypoxia). Whilst TGFβ increased the rate of fibrillar collagen synthesis, HIF pathway activation was required to dysregulate post-translational modification of fibrillar collagen, promoting pyridinoline cross-linking, altering collagen nanostructure, and increasing tissue stiffness. In vitro, knockdown of Factor Inhibiting HIF (FIH), which modulates HIF activity, or oxidative stress caused pseudohypoxic HIF activation in the normal fibroblasts. By contrast, endogenous FIH activity was reduced in fibroblasts from patients with lung fibrosis in association with significantly increased normoxic HIF pathway activation. In human lung fibrosis tissue, HIF-mediated signalling was increased at sites of active fibrogenesis whilst subpopulations of human lung fibrosis mesenchymal cells had increases in both HIF and oxidative stress scores. Our data demonstrate that oxidative stress can drive pseudohypoxic HIF pathway activation which is a critical regulator of pathogenetic collagen structure-function in fibrosis.
- Published
- 2022
- Full Text
- View/download PDF
17. Author response: Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
- Author
-
Liudi Yao, Christopher J Brereton, Elizabeth R Davies, Yilu Zhou, Milica Vukmirovic, Joseph A Bell, Siyuan Wang, Robert A Ridley, Lareb SN Dean, Orestis G Andriotis, Franco Conforti, Lennart Brewitz, Soran Mohammed, Timothy Wallis, Ali Tavassoli, Rob M Ewing, Aiman Alzetani, Benjamin G Marshall, Sophie V Fletcher, Philipp J Thurner, Aurelie Fabre, Naftali Kaminski, Luca Richeldi, Atul Bhaskar, Christopher J Schofield, Matthew Loxham, Donna E Davies, Yihua Wang, and Mark G Jones
- Published
- 2021
- Full Text
- View/download PDF
18. Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer
- Author
-
Ferhat Ay, Serena J Chee, Sourya Bhattacharyya, Tilman Sanchez-Elsner, Edwin Woo, Katy J. McCann, Christopher J. Hanley, Christian H. Ottensmeier, Anusha-Preethi Ganesan, Emma King, Aiman Alzetani, Simon Eschweiler, Ravindra Gujar, Bharat Panwar, Oliver Wood, Peter S Friedmann, Gareth J. Thomas, James Clarke, Pandurangan Vijayanand, Ariel Madrigal, Amiera S Awad, Grégory Seumois, and Divya Singh
- Subjects
Cytotoxicity, Immunologic ,0301 basic medicine ,Lung Neoplasms ,Transcription, Genetic ,T-Lymphocytes ,Programmed Cell Death 1 Receptor ,Immunology ,Cell ,Biology ,Article ,Transcriptome ,03 medical and health sciences ,Lymphocytes, Tumor-Infiltrating ,0302 clinical medicine ,Immune system ,Single-cell analysis ,medicine ,Humans ,Immunology and Allergy ,RNA, Messenger ,Lung cancer ,Hepatitis A Virus Cellular Receptor 2 ,Lung ,Research Articles ,Cell Proliferation ,Cell growth ,Gene Expression Profiling ,medicine.disease ,Lymphocyte Subsets ,Clone Cells ,3. Good health ,CTL ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cancer research ,Single-Cell Analysis ,Immunologic Memory ,Ex vivo - Abstract
Clarke et al. interrogate human TRM cells from cancer and nonmalignant tissue. These analyses highlight that PD-1 expression in tumor-infiltrating TRM cells was positively correlated with features suggestive of active proliferation and superior functionality rather than dysfunction., High numbers of tissue-resident memory T (TRM) cells are associated with better clinical outcomes in cancer patients. However, the molecular characteristics that drive their efficient immune response to tumors are poorly understood. Here, single-cell and bulk transcriptomic analysis of TRM and non-TRM cells present in tumor and normal lung tissue from patients with lung cancer revealed that PD-1–expressing TRM cells in tumors were clonally expanded and enriched for transcripts linked to cell proliferation and cytotoxicity when compared with PD-1–expressing non-TRM cells. This feature was more prominent in the TRM cell subset coexpressing PD-1 and TIM-3, and it was validated by functional assays ex vivo and also reflected in their chromatin accessibility profile. This PD-1+TIM-3+ TRM cell subset was enriched in responders to PD-1 inhibitors and in tumors with a greater magnitude of CTL responses. These data highlight that not all CTLs expressing PD-1 are dysfunctional; on the contrary, TRM cells with PD-1 expression were enriched for features suggestive of superior functionality., Graphical Abstract
- Published
- 2019
- Full Text
- View/download PDF
19. Immunofluorescence-guided segmentation of three-dimensional features in micro-computed tomography datasets of human lung tissue
- Author
-
Peter M. Lackie, Matthew J. Lawson, Philipp Schneider, David S. Chatelet, Oliver Larkin, Ian Haig, Aiman Alzetani, Orestis L. Katsamenis, and Jane Warner
- Subjects
Multidisciplinary ,Materials science ,medicine.diagnostic_test ,Micro computed tomography ,Science ,correlative imaging ,Soft tissue ,warping ,Immunofluorescence ,blood vessel networks ,Human lung ,histology ,medicine.anatomical_structure ,registration ,SIFT ,medicine ,Segmentation ,Tomography ,Correlative imaging ,Biochemistry, Cellular and Molecular Biology ,Research Articles ,Biomedical engineering - Abstract
Micro-computed tomography (µCT) provides non-destructive three-dimensional (3D) imaging of soft tissue microstructures. Specific features in µCT images can be identified using correlated two-dimensional (2D) histology images allowing manual segmentation. However, this is very time-consuming and requires specialist knowledge of the tissue and imaging modalities involved. Using a custom-designed µCT system optimized for imaging unstained formalin-fixed paraffin-embedded soft tissues, we imaged human lung tissue at isotropic voxel sizes less than 10 µm. Tissue sections were stained with haematoxylin and eosin or cytokeratin 18 in columnar airway epithelial cells using immunofluorescence (IF), as an exemplar of this workflow. Novel utilization of tissue autofluorescence allowed automatic alignment of 2D microscopy images to the 3D µCT data using scripted co-registration and automated image warping algorithms. Warped IF images, which were accurately aligned with the µCT datasets, allowed 3D segmentation of immunoreactive tissue microstructures in the human lung. Blood vessels were segmented semi-automatically using the co-registered µCT datasets. Correlating 2D IF and 3D µCT data enables accurate identification, localization and segmentation of features in fixed soft lung tissue. Our novel correlative imaging workflow provides faster and more automated 3D segmentation of µCT datasets. This is applicable to the huge range of formalin-fixed paraffin-embedded tissues held in biobanks and archives.
- Published
- 2021
20. Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
- Author
-
Matthew Loxham, Mark Jones, Robert A. Ridley, Tim Wallis, Mohammed S, Rob M. Ewing, Yilu Zhou, Elizabeth R. Davies, Ben G. Marshall, Philipp J. Thurner, Tavassoli A, Milica Vukmirovic, Naftali Kaminski, Yihua Wang, Aiman Alzetani, Aurelie Fabre, Sophie V. Fletcher, Franco Conforti, Lareb S. N. Dean, Liudi Yao, Joseph Bell, Donna E. Davies, Atul Bhaskar, Christopher J. Brereton, Luca Richeldi, and Orestis G. Andriotis
- Subjects
Extracellular matrix ,Chemistry ,Fibrosis ,Mesenchymal stem cell ,medicine ,Endogeny ,Mechanosensitive channels ,medicine.disease ,medicine.disease_cause ,Ex vivo ,In vitro ,Oxidative stress ,Cell biology - Abstract
Extracellular matrix (ECM) stiffening with downstream activation of mechanosensitive pathways is strongly implicated in fibrosis. We previously reported that altered collagen nanoarchitecture is a key determinant of pathogenetic ECM structure-function in human fibrosis (Jones et al., 2018). Here, through human tissue, bioinformatic and ex vivo studies we show that hypoxia-inducible factor (HIF) pathway activation is a critical pathway for this process regardless of oxygen status (pseudohypoxia). Whilst TGFβ increased rate of fibrillar collagen synthesis, HIF pathway activation was required to dysregulate post-translational modification of fibrillar collagen, promoting ‘bone-type’ cross-linking, altering collagen nanostructure, and increasing tissue stiffness. In vitro, knock down of Factor Inhibiting HIF (FIH) or oxidative stress caused pseudohypoxic HIF activation in normal fibroblasts. In contrast, endogenous FIH activity was reduced in fibroblasts from patients with lung fibrosis in association with significantly increased normoxic HIF pathway activation. In human lung fibrosis tissue, HIF mediated signalling was increased at sites of active fibrogenesis whilst subpopulations of IPF lung mesenchymal cells had increases in both HIF and oxidative stress scores. Our data demonstrate that oxidative stress can drive pseudohypoxic HIF pathway activation which is a critical regulator of pathogenetic collagen structure-function in fibrosis.
- Published
- 2021
- Full Text
- View/download PDF
21. Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study)
- Author
-
Gianluca Casali, Jennifer Lamb, Chris A Rogers, Aiman Alzetani, Holly E. Mckeon, Nicholas Goddard, Ben Gibbison, Elizabeth A Stokes, Reyad Abbadi, Maria Pufulete, Nilesh Chauhan, Samantha E de Jesus, Mat Molyneux, Lucy Culliford, Laura Collett, Mark R Edwards, Sarah Wordsworth, and Sarah Baos
- Subjects
Adult ,medicine.medical_specialty ,Randomised controlled trial (RCT) ,Blinding ,Gabapentin ,Adolescent ,Cost effectiveness ,gabapentin ,Cost-Benefit Analysis ,Placebo ,surgical patients ,law.invention ,Anaesthesia ,surgery ,Randomized controlled trial ,Double-Blind Method ,law ,medicine ,Humans ,Multicenter Studies as Topic ,Randomized Controlled Trials as Topic ,clinical trials ,Pain, Postoperative ,business.industry ,peri-operative ,General Medicine ,Perioperative ,Clinical trial ,pain management ,Neuropathic pain ,Physical therapy ,placebo ,Quality of Life ,Medicine ,business ,medicine.drug ,Anaesthesia Pain and Critical Care - Abstract
IntroductionGabapentin is an antiepileptic drug currently licensed to treat epilepsy and neuropathic pain but has been used off-label to treat acute postoperative pain. The GAP study will compare the effectiveness, cost-effectiveness and safety of gabapentin as an adjunct to standard multimodal analgesia versus placebo for the management of pain after major surgery.Methods and analysisThe GAP study is a multicentre, double-blind, randomised controlled trial in patients aged 18 years and over, undergoing different types of major surgery (cardiac, thoracic or abdominal). Patients will be randomised in a 1:1 ratio to receive either gabapentin (600 mg just before surgery and 600 mg/day for 2 days after surgery) or placebo in addition to usual pain management for each type of surgery. Patients will be followed up daily until hospital discharge and then at 4 weeks and 4 months after surgery. The primary outcome is length of hospital stay following surgery. Secondary outcomes include pain, total opioid use, adverse health events, health related quality of life and costs.Ethics and disseminationThis study has been approved by the Research Ethics Committee . Findings will be shared with participating hospitals and disseminated to the academic community through peer-reviewed publications and presentation at national and international meetings. Patients will be informed of the results through patient organisations and participant newsletters.Trial registration numberISRCTN63614165.
- Published
- 2021
- Full Text
- View/download PDF
22. Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis
- Author
-
Tim Wallis, David C. Hancock, Aiman Alzetani, Anna Rattu, Rob M. Ewing, Ben G. Marshall, Yilu Zhou, Mark Jones, Franco Conforti, Julian Downward, Paul Skipp, Leanne Wickens, Donna E. Davies, Juanjuan Li, Sophie V. Fletcher, Fathima Maneesha Ibrahim, Luca Richeldi, Liudi Yao, and Yihua Wang
- Subjects
Male ,NHLF, normal human lung fibroblast ,ZEB1, zinc finger E-box-binding homeobox 1 ,Gene Expression ,Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO ,epithelial–mesenchymal transition ,Biochemistry ,GSVA, gene set variation analysis ,Extracellular matrix ,Idiopathic pulmonary fibrosis ,Fibrosis ,Cell Movement ,Transforming Growth Factor beta ,Pulmonary fibrosis ,DEG, differentially expressed gene ,ZEB1 ,Lung ,Chemical Biology & High Throughput ,CM, conditioned media ,Chemistry ,respiratory system ,Cell biology ,ECM, extracellular matrix ,Extracellular Matrix ,Crosstalk (biology) ,Tissue Plasminogen Activator ,Female ,EMT, epithelial–mesenchymal transition ,Genetics & Genomics ,Research Article ,TGF-β ,Model organisms ,Epithelial-Mesenchymal Transition ,FDR, false discovery rate ,EGFR ,Primary Cell Culture ,4-OHT, 4-hydroxytamoxifen ,SPARC, secreted protein acidic and rich in cysteine ,ERK, extracellular-regulated kinase ,α-SMA, α-smooth muscle actin ,Paracrine signalling ,Signalling & Oncogenes ,Growth factor receptor ,TGF-β, transforming growth factor-β ,GO, Gene Ontology ,medicine ,IPF, idiopathic pulmonary fibrosis ,Humans ,Epithelial–mesenchymal transition ,Molecular Biology ,IPFF, IPF fibroblast ,pulmonary fibrosis ,Zinc Finger E-box-Binding Homeobox 1 ,Epithelial Cells ,SPARC ,Cell Biology ,Fibroblasts ,Tumour Biology ,medicine.disease ,tPA, tissue plasminogen activator ,Idiopathic Pulmonary Fibrosis ,EGFR, epithelial growth factor receptor ,ATII, alveolar epithelial type II ,RAS - Abstract
Idiopathic pulmonary fibrosis (IPF) is the prototypic progressive fibrotic lung disease with a median survival of 2 to 4 years. Injury to and/or dysfunction of the alveolar epithelium is strongly implicated in IPF disease initiation, but the factors that determine whether fibrosis progresses rather than normal tissue repair occurs remain poorly understood. We previously demonstrated that zinc finger E-box-binding homeobox 1-mediated epithelial-mesenchymal transition in human alveolar epithelial type II (ATII) cells augments transforming growth factor-β-induced profibrogenic responses in underlying lung fibroblasts via paracrine signaling. Here, we investigated bidirectional epithelial-mesenchymal crosstalk and its potential to drive fibrosis progression. RNA-Seq of lung fibroblasts exposed to conditioned media from ATII cells undergoing RAS-induced epithelial-mesenchymal transition identified many differentially expressed genes including those involved in cell migration and extracellular matrix regulation. We confirmed that paracrine signaling between RAS-activated ATII cells and fibroblasts augmented fibroblast recruitment and demonstrated that this involved a zinc finger E-box-binding homeobox 1-tissue plasminogen activator axis. In a reciprocal fashion, paracrine signaling from transforming growth factor-β-activated lung fibroblasts or IPF fibroblasts induced RAS activation in ATII cells, at least partially through the secreted protein acidic and rich in cysteine, which may signal via the epithelial growth factor receptor via epithelial growth factor-like repeats. Together, these data identify that aberrant bidirectional epithelial-mesenchymal crosstalk in IPF drives a chronic feedback loop that maintains a wound-healing phenotype and provides self-sustaining profibrotic signals.
- Published
- 2021
- Full Text
- View/download PDF
23. Tracheal leiomyoma mimicking asthma for over 20 years
- Author
-
Oliver J. Harrison, Mark Jackson, Aiman Alzetani, and Emily C. Shaw
- Subjects
Spirometry ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Incidence (epidemiology) ,Case Report ,Computed tomography ,Tracheal Leiomyoma ,respiratory system ,Airway obstruction ,medicine.disease ,Resection ,03 medical and health sciences ,0302 clinical medicine ,Leiomyoma ,030228 respiratory system ,030225 pediatrics ,medicine ,Surgery ,Radiology ,business ,Asthma - Abstract
Benign tracheal tumours have an incidence of 1 in 1,000,000, of which leiomyomas represent only 1%. We report a case of tracheal leiomyoma masquerading as asthma for over 20 years. A 48-year-old man presented aged 26 years with asthma symptoms unresponsive to treatments and an obstructive spirometry pattern. Symptoms were not particularly troubling but suddenly exacerbated 22 years later. Flow-volume studies were consistent with upper airway obstruction. Computed tomography chest revealed a 2.3 cm mass arising from the posterior aspect of the trachea 2 cm above the carina. Bronchoscopic resection was performed using a Nd:YAG laser. Histology confirmed leiomyoma. Follow-up after 6 weeks revealed complete resolution of symptoms with normal spirometry. Tracheal masses should be considered in any patient with atypical asthma. A flow-volume loop may provide a clue to diagnosis and bronchoscopic laser resection is a minimally invasive treatment option.
- Published
- 2020
- Full Text
- View/download PDF
24. M1hot tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer
- Author
-
Christian H. Ottensmeier, Catherine C. Hedrick, Serena J Chee, Anusha-Preethi Ganesan, Tilman Sanchez-Elsner, Eva M. Garrido-Martin, Pandurangan Vijayanand, Emma King, Angelica Cazaly, Oliver Wood, Toby Mellows, James Clarke, Peter S. Friedmann, Gareth J. Thomas, Aiman Alzetani, and Grégory Seumois
- Subjects
0301 basic medicine ,Cancer Research ,Chemokine ,Immunology ,Biology ,Transcriptome ,03 medical and health sciences ,0302 clinical medicine ,stomatognathic system ,medicine ,Immunology and Allergy ,skin and connective tissue diseases ,Lung cancer ,RC254-282 ,Pharmacology ,Tumor microenvironment ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Acquired immune system ,medicine.disease ,Phenotype ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Molecular Medicine ,CXCL9 ,CD8 - Abstract
BackgroundThe role of tumor-associated macrophages (TAMs) in determining the outcome between the antitumor effects of the adaptive immune system and the tumor’s anti-immunity stratagems, is controversial. Macrophages modulate their activities and phenotypes by integration of signals in the tumor microenvironment. Depending on how macrophages are activated, they may adopt so-called M1-like, antitumor or M2-like, protumor profiles. In many solid tumors, a dominance of M2-like macrophages is associated with poor outcomes but in some tumor types, strong M1-like profiles are linked to better outcomes. We aimed to investigate the interrelationship of these TAM populations to establish how they modulate the efficacy of the adaptive immune system in early lung cancer.MethodsMacrophages from matched lung (non-tumor-associated macrophages (NTAMs)) and tumor samples (TAMs) from resected lung cancers were assessed by bulk and single-cell transcriptomic analysis. Protein expression of genes characteristic of M1-like (chemokine (C-X-C motif) ligand 9) or M2-like (matrix metallopeptidase 12) functions was confirmed by confocal microscopy. Immunohistochemistry related the distribution of TAM transcriptomic signatures to density of CD8+tissue-resident memory T cells (TRM) in tumors and survival data from an independent cohort of 393 patients with lung cancer.ResultsTAMs have significantly different transcriptomic profiles from NTAMs with >1000 differentially expressed genes. TAMs displayed a strong M2-like signature with no significant variation between patients. However, single-cell RNA-sequencing supported by immuno-stained cells revealed that additionally, in 25% of patients the M2-like TAMs also co-expressed a strong/hot M1-like signature (M1hot). Importantly, there was a strong association between the density of M1hotTAMs and TRMcells in tumors that was in turn linked to better survival. Our data suggest a mechanism by which M1hotTAMs may recruit TRMcells via CXCL9 expression and sustain them by making available more of the essential fatty acids on which TRMdepend.ConclusionsWe showed that in early lung cancer, expression of M1-like and M2-like gene signatures are not mutually exclusive since the same TAMs can simultaneously display both gene-expression profiles. The presence of M1hotTAMs was associated with a strong TRMtumor-infiltrate and better outcomes. Thus, therapeutic approaches to re-program TAMs to an M1hotphenotype are likely to augment the adaptive antitumor responses.
- Published
- 2020
25. Delayed post-traumatic presentation of severe sternal osteomyelitis: A strong multidisciplinary effort and a novel reconstruction technique for a challenging case
- Author
-
Oliver Harrison, Alessandro Tamburrini, Mansoor Khan, Hanad Ahmed, Aiman Alzetani, Simon Tilley, and Thomas Talbot
- Subjects
medicine.medical_specialty ,Sternum ,medicine.medical_treatment ,lcsh:Surgery ,Case Report ,Critical Care and Intensive Care Medicine ,Iliac crest ,03 medical and health sciences ,0302 clinical medicine ,Blunt ,medicine ,Internal fixation ,Orthopedics and Sports Medicine ,030222 orthopedics ,business.industry ,Osteomyelitis ,Sternal osteomyelitis ,030208 emergency & critical care medicine ,Fascia ,lcsh:RD1-811 ,medicine.disease ,musculoskeletal system ,Surgery ,Chest wall trauma ,medicine.anatomical_structure ,surgical procedures, operative ,Clavicle ,Emergency Medicine ,business ,Chest wall reconstruction ,Subcutaneous tissue - Abstract
Sternal osteomyelitis is a morbid and challenging condition, which can rarely occur after trauma, with no established consensus over best therapeutic options. In this case, a 47-year-old man with history of intravenous drug use presented 11 weeks after a minor blunt chest trauma with a severe necrotizing osteomyelitis involving sternum, muscles, fascia and subcutaneous tissue and positive blood cultures for Methicillin Sensitive Staphylococcus aureus. Alongside tailored antibiotic therapy, extensive surgical debridement was performed, leaving a full thickness 3 × 4 cm sternal defect and a large skin defect. After 4 weeks of antibiotics and Vacuum-Assisted-Closure pump, a novel reconstruction technique was utilized, with full collaborations of thoracic surgeons, orthopaedic surgeons and plastic surgeons. An autologous tricortical iliac crest bone graft was harvested and shaped to fit the full-thickness sternal defect, while two titanium sigmoid-shaped clavicle plates were used for internal fixation of the autograft. The large skin defect was covered with a pedicled myocutaneous latissimus dorsi flap. Integrity and stability of the chest wall was fully restored, and infection was completely eradicated. No complications occurred and the patient was well at the 18 months follow-up. To the best of our knowledge, this is the first report on autologous iliac crest bone graft in the treatment of sternal osteomyelitis. In this case, it proved to be a viable therapeutic option, providing good long-term clinical and cosmetic results.
- Published
- 2020
26. M1
- Author
-
Eva M, Garrido-Martin, Toby W P, Mellows, James, Clarke, Anusha-Preethi, Ganesan, Oliver, Wood, Angelica, Cazaly, Gregory, Seumois, Serena J, Chee, Aiman, Alzetani, Emma V, King, Catherine C, Hedrick, Gareth, Thomas, Peter S, Friedmann, Christian Hermann, Ottensmeier, Pandurangan, Vijayanand, and Tilman, Sanchez-Elsner
- Subjects
Male ,immunity, innate ,Lung Neoplasms ,T-Lymphocytes ,Basic Tumor Immunology ,Survival Analysis ,immunity ,macrophages ,stomatognathic system ,Tumor-Associated Macrophages ,Humans ,Female - Abstract
Background The role of tumor-associated macrophages (TAMs) in determining the outcome between the antitumor effects of the adaptive immune system and the tumor’s anti-immunity stratagems, is controversial. Macrophages modulate their activities and phenotypes by integration of signals in the tumor microenvironment. Depending on how macrophages are activated, they may adopt so-called M1-like, antitumor or M2-like, protumor profiles. In many solid tumors, a dominance of M2-like macrophages is associated with poor outcomes but in some tumor types, strong M1-like profiles are linked to better outcomes. We aimed to investigate the interrelationship of these TAM populations to establish how they modulate the efficacy of the adaptive immune system in early lung cancer. Methods Macrophages from matched lung (non-tumor-associated macrophages (NTAMs)) and tumor samples (TAMs) from resected lung cancers were assessed by bulk and single-cell transcriptomic analysis. Protein expression of genes characteristic of M1-like (chemokine (C-X-C motif) ligand 9) or M2-like (matrix metallopeptidase 12) functions was confirmed by confocal microscopy. Immunohistochemistry related the distribution of TAM transcriptomic signatures to density of CD8+ tissue-resident memory T cells (TRM) in tumors and survival data from an independent cohort of 393 patients with lung cancer. Results TAMs have significantly different transcriptomic profiles from NTAMs with >1000 differentially expressed genes. TAMs displayed a strong M2-like signature with no significant variation between patients. However, single-cell RNA-sequencing supported by immuno-stained cells revealed that additionally, in 25% of patients the M2-like TAMs also co-expressed a strong/hot M1-like signature (M1hot). Importantly, there was a strong association between the density of M1hot TAMs and TRM cells in tumors that was in turn linked to better survival. Our data suggest a mechanism by which M1hot TAMs may recruit TRM cells via CXCL9 expression and sustain them by making available more of the essential fatty acids on which TRM depend. Conclusions We showed that in early lung cancer, expression of M1-like and M2-like gene signatures are not mutually exclusive since the same TAMs can simultaneously display both gene-expression profiles. The presence of M1hot TAMs was associated with a strong TRM tumor-infiltrate and better outcomes. Thus, therapeutic approaches to re-program TAMs to an M1hot phenotype are likely to augment the adaptive antitumor responses.
- Published
- 2020
27. CD4+ follicular helper-like T cells are key players in anti-tumor immunity
- Author
-
Tilman Sanchez-Elsner, Bharat Panwar, James Clarke, Christian H. Ottensmeier, Serena J Chee, Ciro Ramírez-Suástegui, Ariel Madrigal, Eva M. Garrido-Martin, Ferhat Ay, Wang A, Singh D, Aiman Alzetani, Oliver Wood, Grégory Seumois, Anusha-Preethi Ganesan, Simon Eschweiler, Shane Crotty, Friedmann P, Pandurangan Vijayanand, Simon Bélanger, Gareth J. Thomas, Edwin Woo, and Christopher J. Hanley
- Subjects
Transcriptome ,CTL ,Adoptive cell transfer ,medicine.anatomical_structure ,Immunity ,T cell ,medicine ,Cancer research ,Cytotoxic T cell ,Biology ,CD8 ,Blockade - Abstract
To determine the nature of CD4+ T cells that provide ‘help’ for generating robust anti-tumor CD8+ cytotoxic T cell (CTL) responses, we profiled the transcriptomes of patient-matched CD4+ and CD8+ T cells present in the tumor micro-environment (TME) and analyzed them jointly using integrated weighted gene correlation network analysis. We found the follicular helper T cell (TFH) program in CD4+ T cells was strongly associated with proliferation and tissue-residency in CD8+ CTLs. Single-cell analysis demonstrated the presence of TFH-like cells and features linked to cytotoxic function and their provision of CD8+ T cell ‘help’. Tumor-infiltrating TFH-like cells expressed PD-1 and were enriched in tumors following checkpoint blockade, suggesting that they may respond to anti-PD-1 therapy. Adoptive transfer or induction of TFH cells in mouse models resulted in augmented CD8+ CTL responses and impairment of tumor growth, indicating an important role of TFH-like CD4+ T cells in anti-tumor immunity.
- Published
- 2020
- Full Text
- View/download PDF
28. Paracrine SPARC signaling dysregulates alveolar epithelial barrier integrity and function in lung fibrosis
- Author
-
Donna E. Davies, Mark Jones, Robert A. Ridley, Sophie V. Fletcher, Yihua Wang, Aiman Alzetani, Ben G. Marshall, Franco Conforti, Christian H. Ottensmeier, Benjamin Johnson, Luca Richeldi, Christopher J. Brereton, and Paul Skipp
- Subjects
0301 basic medicine ,Cancer Research ,Alveolar Epithelium ,Immunology ,Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Idiopathic pulmonary fibrosis ,Paracrine signalling ,0302 clinical medicine ,Medicine ,lcsh:QH573-671 ,Fibroblast ,Tissue homeostasis ,Lung ,business.industry ,lcsh:Cytology ,Matricellular protein ,Cell Biology ,Environmental exposure ,respiratory system ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Cell biology ,Experimental models of disease ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Extracellular signalling molecules ,business - Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic scarring disease in which aging, environmental exposure(s) and genetic susceptibility have been implicated in disease pathogenesis, however, the causes and mechanisms of the progressive fibrotic cascade are still poorly understood. As epithelial–mesenchymal interactions are essential for normal wound healing, through human 2D and 3D in vitro studies, we tested the hypothesis that IPF fibroblasts (IPFFs) dysregulate alveolar epithelial homeostasis. Conditioned media from IPFFs exaggerated the wound-healing response of primary human Type II alveolar epithelial cells (AECs). Furthermore, AECs co-cultured with IPFFs exhibited irregular epithelialization compared with those co-cultured with control fibroblasts (NHLFs) or AECs alone, suggesting that epithelial homeostasis is dysregulated in IPF as a consequence of the abnormal secretory phenotype of IPFFs. Secretome analysis of IPFF conditioned media and functional studies identified the matricellular protein, SPARC, as a key mediator in the epithelial–mesenchymal paracrine signaling, with increased secretion of SPARC by IPFFs promoting persistent activation of alveolar epithelium via an integrin/focal adhesion/cellular-junction axis resulting in disruption of epithelial barrier integrity and increased macromolecular permeability. These findings suggest that in IPF fibroblast paracrine signaling promotes persistent alveolar epithelial activation, so preventing normal epithelial repair responses and restoration of tissue homeostasis. Furthermore, they identify SPARC-mediated paracrine signaling as a potential therapeutic target to promote the restoration of lung epithelial homoestasis in IPF patients.
- Published
- 2020
29. Vasomotion Drives Periarterial Drainage of Aβ from the Brain
- Author
-
Aiman Alzetani, Roxana-Octavia Carare, A.A. Birch, Roxana Aldea, Roy O. Weller, Giles Richardson, and Diedrik Bulters
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Chemistry ,General Neuroscience ,Vasomotion ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Internal medicine ,medicine ,Cardiology ,Wakefulness ,Neuron ,030217 neurology & neurosurgery - Abstract
In this issue of Neuron, van Veluw et al. (2020) show that elimination of solutes from the brain along arterial walls is driven by low-frequency arteriolar oscillations and suggest that age-related reduction of this vasomotion may contribute to impaired clearance of Aβ.
- Published
- 2020
- Full Text
- View/download PDF
30. Author response: Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
- Author
-
Martin Kolb, Peter Johnson, Mark Jones, Orestis G. Andriotis, Christian H. Ottensmeier, James Roberts, Lucy Cao, Serena J Chee, Alessandra Bonfanti, Ben G. Marshall, Regan Doherty, Benjamin Johnson, David E. Smart, Donna E. Davies, Atul Bhaskar, Philipp J. Thurner, Franco Conforti, Chester Lai, Aiman Alzetani, Victoria Tear, Kjetil Ask, Wolfgang Jarolimek, Aurelie Fabre, Christopher J. Brereton, Konstantinos N. Bourdakos, Jack Gauldie, Kerry Lunn, Luca Richeldi, Katherine M.A. O'Reilly, Sumeet Mahajan, Sophie V. Fletcher, Sanjay Jogai, Patricia J. Sime, and Phillip Monk
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,Chemistry ,Pulmonary fibrosis ,Structure function ,medicine ,medicine.disease ,Homeostasis ,Cell biology - Published
- 2018
- Full Text
- View/download PDF
31. Paracrine signalling during ZEB1-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in lung fibrosis
- Author
-
Leena Drawater, Mark J. Coldwell, Joseph Bell, Juanjuan Li, Xianglin Yuan, Sophie V. Fletcher, Franco Conforti, Paul Skipp, David C. Hancock, Charlotte Hill, Rob M. Ewing, Serena J Chee, Liudi Yao, Mark Jones, Julian Downward, Hua Xiong, Yihua Wang, Ben G. Marshall, Donna E. Davies, Aiman Alzetani, Dian Liu, Luca Richeldi, Christian H. Ottensmeier, and Jane E. Collins
- Subjects
0301 basic medicine ,Epithelial-Mesenchymal Transition ,Alveolar Epithelium ,Respiratory Tract Diseases ,Article ,Cell Line ,Extracellular matrix ,03 medical and health sciences ,Paracrine signalling ,0302 clinical medicine ,Paracrine Communication ,Pulmonary fibrosis ,medicine ,Humans ,Epithelial–mesenchymal transition ,Myofibroblasts ,Lung ,Molecular Biology ,Chemistry ,Zinc Finger E-box-Binding Homeobox 1 ,Cell Differentiation ,Epithelial Cells ,Cell Biology ,respiratory system ,medicine.disease ,Fibrosis ,Extracellular Matrix ,3. Good health ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,Gene Expression Regulation ,Cell culture ,030220 oncology & carcinogenesis ,Myofibroblast - Abstract
The contribution of epithelial-mesenchymal transition (EMT) to human lung fibrogenesis is controversial. Here we provide evidence that ZEB1-mediated EMT in human alveolar epithelial type II (ATII) cells contributes to the development of lung fibrosis by paracrine signalling to underlying fibroblasts. Activation of EGFR-RAS-ERK signalling in ATII cells induced EMT via ZEB1. ATII cells had extremely low extracellular matrix gene expression even after induction of EMT, however conditioned media from ATII cells undergoing RAS-induced EMT augmented TGFβ-induced profibrogenic responses in lung fibroblasts. This epithelial-mesenchymal crosstalk was controlled by ZEB1 via the expression of tissue plasminogen activator (tPA). In human fibrotic lung tissue, nuclear ZEB1 expression was detected in alveolar epithelium adjacent to sites of extracellular matrix (ECM) deposition, suggesting that ZEB1-mediated paracrine signalling has the potential to contribute to early fibrotic changes in the lung interstitium. Targeting this novel ZEB1 regulatory axis may be a viable strategy for the treatment of pulmonary fibrosis.
- Published
- 2018
32. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Author
-
Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley, Andrew J. Rowan, Thomas B.K. Watkins, Gareth A. Wilson, Nicolai J. Birkbak, Selvaraju Veeriah, Peter Van Loo, Javier Herrero, Charles Swanton, Mariam Jamal-Hanjani, Seema Shafi, Justyna Czyzewska-Khan, Diana Johnson, Joanne Laycock, Leticia Bosshard-Carter, Pat Gorman, Robert E. Hynds, Gareth Wilson, Stuart Horswell, Richard Mitter, Mickael Escudero, Aengus Stewart, Andrew Rowan, Hang Xu, Samra Turajlic, Crispin Hiley, Christopher Abbosh, Jacki Goldman, Richard Kevin Stone, Tamara Denner, Nik Matthews, Greg Elgar, Sophia Ward, Marta Costa, Sharmin Begum, Ben Phillimore, Tim Chambers, Emma Nye, Sofia Graca, Maise Al Bakir, Kroopa Joshi, Andrew Furness, Assma Ben Aissa, Yien Ning Sophia Wong, Andy Georgiou, Sergio Quezada, John A. Hartley, Helen L. Lowe, David Lawrence, Martin Hayward, Nikolaos Panagiotopoulos, Shyam Kolvekar, Mary Falzon, Elaine Borg, Teresa Marafioti, Celia Simeon, Gemma Hector, Amy Smith, Marie Aranda, Marco Novelli, Dahmane Oukrif, Sam M. Janes, Ricky Thakrar, Martin Forster, Tanya Ahmad, Siow Ming Lee, Dionysis Papadatos-Pastos, Dawn Carnell, Ruheena Mendes, Jeremy George, Neal Navani, Asia Ahmed, Magali Taylor, Junaid Choudhary, Yvonne Summers, Raffaele Califano, Paul Taylor, Rajesh Shah, Piotr Krysiak, Kendadai Rammohan, Eustace Fontaine, Richard Booton, Matthew Evison, Phil Crosbie, Stuart Moss, Faiza Idries, Leena Joseph, Paul Bishop, Anshuman Chaturved, Anne Marie Quinn, Helen Doran, Angela Leek, Phil Harrison, Katrina Moore, Rachael Waddington, Juliette Novasio, Fiona Blackhall, Jane Rogan, Elaine Smith, Caroline Dive, Jonathan Tugwood, Ged Brady, Dominic G. Rothwell, Francesca Chemi, Jackie Pierce, Sakshi Gulati, Babu Naidu, Gerald Langman, Simon Trotter, Mary Bellamy, Hollie Bancroft, Amy Kerr, Salma Kadiri, Joanne Webb, Gary Middleton, Madava Djearaman, Dean Fennell, Jacqui A. Shaw, John Le Quesne, David Moore, Apostolos Nakas, Sridhar Rathinam, William Monteiro, Hilary Marshall, Louise Nelson, Jonathan Bennett, Joan Riley, Lindsay Primrose, Luke Martinson, Girija Anand, Sajid Khan, Anita Amadi, Marianne Nicolson, Keith Kerr, Shirley Palmer, Hardy Remmen, Joy Miller, Keith Buchan, Mahendran Chetty, Lesley Gomersall, Jason Lester, Alison Edwards, Fiona Morgan, Haydn Adams, Helen Davies, Malgorzata Kornaszewska, Richard Attanoos, Sara Lock, Azmina Verjee, Mairead MacKenzie, Maggie Wilcox, Harriet Bell, Allan Hackshaw, Yenting Ngai, Sean Smith, Nicole Gower, Christian Ottensmeier, Serena Chee, Benjamin Johnson, Aiman Alzetani, Emily Shaw, Eric Lim, Paulo De Sousa, Monica Tavares Barbosa, Alex Bowman, Simon Jordan, Alexandra Rice, Hilgardt Raubenheimer, Chiara Proli, Maria Elena Cufari, John Carlo Ronquillo, Angela Kwayie, Harshil Bhayani, Morag Hamilton, Yusura Bakar, Natalie Mensah, Lyn Ambrose, Anand Devaraj, Silviu Buderi, Jonathan Finch, Leire Azcarate, Hema Chavan, Sophie Green, Hillaria Mashinga, Andrew G. Nicholson, Kelvin Lau, Michael Sheaff, Peter Schmid, John Conibear, Veni Ezhil, Babikir Ismail, Melanie Irvin-sellers, Vineet Prakash, Peter Russell, Teresa Light, Tracey Horey, Sarah Danson, Jonathan Bury, John Edwards, Jennifer Hill, Sue Matthews, Yota Kitsanta, Kim Suvarna, Patricia Fisher, Allah Dino Keerio, Michael Shackcloth, John Gosney, Pieter Postmus, Sarah Feeney, Julius Asante-Siaw, Hugo J.W.L. Aerts, Stefan Dentro, Christophe Dessimoz, TRACERx Consortium, Swanton, C., Jamal-Hanjani, M., Veeriah, S., Shafi, S., Czyzewska-Khan, J., Johnson, D., Laycock, J., Bosshard-Carter, L., Rosenthal, R., Gorman, P., Hynds, R.E., Wilson, G., Birkbak, N.J., Watkins, TBK, McGranahan, N., Horswell, S., Mitter, R., Escudero, M., Stewart, A., Van Loo, P., Rowan, A., Xu, H., Turajlic, S., Hiley, C., Abbosh, C., Goldman, J., Stone, R.K., Denner, T., Matthews, N., Elgar, G., Ward, S., Costa, M., Begum, S., Phillimore, B., Chambers, T., Nye, E., Graca, S., Al Bakir, M., Joshi, K., Furness, A., Ben Aissa, A., Wong, YNS, Georgiou, A., Quezada, S., Hartley, J.A., Lowe, H.L., Herrero, J., Lawrence, D., Hayward, M., Panagiotopoulos, N., Kolvekar, S., Falzon, M., Borg, E., Marafioti, T., Simeon, C., Hector, G., Smith, A., Aranda, M., Novelli, M., Oukrif, D., Janes, S.M., Thakrar, R., Forster, M., Ahmad, T., Lee, S.M., Papadatos-Pastos, D., Carnell, D., Mendes, R., George, J., Navani, N., Ahmed, A., Taylor, M., Choudhary, J., Summers, Y., Califano, R., Taylor, P., Shah, R., Krysiak, P., Rammohan, K., Fontaine, E., Booton, R., Evison, M., Crosbie, P., Moss, S., Idries, F., Joseph, L., Bishop, P., Chaturved, A., Quinn, A.M., Doran, H., Leek, A., Harrison, P., Moore, K., Waddington, R., Novasio, J., Blackhall, F., Rogan, J., Smith, E., Dive, C., Tugwood, J., Brady, G., Rothwell, D.G., Chemi, F., Pierce, J., Gulati, S., Naidu, B., Langman, G., Trotter, S., Bellamy, M., Bancroft, H., Kerr, A., Kadiri, S., Webb, J., Middleton, G., Djearaman, M., Fennell, D., Shaw, J.A., Le Quesne, J., Moore, D., Nakas, A., Rathinam, S., Monteiro, W., Marshall, H., Nelson, L., Bennett, J., Riley, J., Primrose, L., Martinson, L., Anand, G., Khan, S., Amadi, A., Nicolson, M., Kerr, K., Palmer, S., Remmen, H., Miller, J., Buchan, K., Chetty, M., Gomersall, L., Lester, J., Edwards, A., Morgan, F., Adams, H., Davies, H., Kornaszewska, M., Attanoos, R., Lock, S., Verjee, A., MacKenzie, M., Wilcox, M., Bell, H., Hackshaw, A., Ngai, Y., Smith, S., Gower, N., Ottensmeier, C., Chee, S., Johnson, B., Alzetani, A., Shaw, E., Lim, E., De Sousa, P., Barbosa, M.T., Bowman, A., Jordan, S., Rice, A., Raubenheimer, H., Proli, C., Cufari, M.E., Ronquillo, J.C., Kwayie, A., Bhayani, H., Hamilton, M., Bakar, Y., Mensah, N., Ambrose, L., Devaraj, A., Buderi, S., Finch, J., Azcarate, L., Chavan, H., Green, S., Mashinga, H., Nicholson, A.G., Lau, K., Sheaff, M., Schmid, P., Conibear, J., Ezhil, V., Ismail, B., Irvin-Sellers, M., Prakash, V., Russell, P., Light, T., Horey, T., Danson, S., Bury, J., Edwards, J., Hill, J., Matthews, S., Kitsanta, Y., Suvarna, K., Fisher, P., Keerio, A.D., Shackcloth, M., Gosney, J., Postmus, P., Feeney, S., Asante-Siaw, J., Aerts, HJWL, Dentro, S., and Dessimoz, C.
- Subjects
Male ,immune-editing ,0301 basic medicine ,DOWN-REGULATION ,immune-escape ,Lung Neoplasms ,Loss of Heterozygosity ,Cohort Studies ,Loss of heterozygosity ,HLA Antigens ,Carcinoma, Non-Small-Cell Lung ,Chromosome instability ,MUTATIONAL PROCESSES ,11 Medical and Health Sciences ,Aged, 80 and over ,Antigen Presentation ,cancer evolution ,Manchester Cancer Research Centre ,bioinformatics ,Middle Aged ,3. Good health ,Female ,loss of heterozygosity ,SENSITIVITY ,Life Sciences & Biomedicine ,Adult ,Biochemistry & Molecular Biology ,chromosomal instability ,Antigen presentation ,Locus (genetics) ,NEOANTIGENS ,Human leukocyte antigen ,Biology ,Polymorphism, Single Nucleotide ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Immune system ,copy number ,medicine ,Humans ,Lung cancer ,Aged ,Science & Technology ,ResearchInstitutes_Networks_Beacons/mcrc ,CTLA-4 BLOCKADE ,Cell Biology ,06 Biological Sciences ,medicine.disease ,PD-1 BLOCKADE ,neoantigen ,lung cancer ,030104 developmental biology ,Carcinoma, Non-Small-Cell Lung/genetics ,Carcinoma, Non-Small-Cell Lung/immunology ,Carcinoma, Non-Small-Cell Lung/pathology ,Carcinoma, Non-Small-Cell Lung/therapy ,HLA Antigens/genetics ,HLA Antigens/immunology ,Lung Neoplasms/genetics ,Lung Neoplasms/immunology ,Lung Neoplasms/pathology ,Lung Neoplasms/therapy ,Mutation ,Tumor Escape ,heterogeneity ,TRACERx Consortium ,DISCOVERY ,CELLS ,Immunology ,RESISTANCE ,Developmental Biology - Abstract
Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. However, the polymorphic nature of the locus has precluded accurate HLA copy-number analysis. Here, we present loss of heterozygosity in human leukocyte antigen (LOHHLA), a computational tool to determine HLA allele-specific copy number from sequencing data. Using LOHHLA, we find that HLA LOH occurs in 40% of non-small-cell lung cancers (NSCLCs) and is associated with a high subclonal neoantigen burden, APOBEC-mediated mutagenesis, upregulation of cytolytic activity, and PD-L1 positivity. The focal nature of HLA LOH alterations, their subclonal frequencies, enrichment in metastatic sites, and occurrence as parallel events suggests that HLA LOH is an immune escape mechanism that is subject to strong microenvironmental selection pressures later in tumor evolution. Characterizing HLA LOH with LOHHLA refines neoantigen prediction and may have implications for our understanding of resistance mechanisms and immunotherapeutic approaches targeting neoantigens. VIDEO ABSTRACT.
- Published
- 2017
- Full Text
- View/download PDF
33. A record-breaking lung metastasis from renal cell carcinoma 37 years after nephrectomy
- Author
-
Alessandro Tamburrini, Sanjay Jogai, Aurelio Majorino, Aiman Alzetani, and Simon Duggan
- Subjects
Oncology ,medicine.medical_specialty ,Lung ,business.industry ,medicine.medical_treatment ,Lung metastasis ,Case Report ,030204 cardiovascular system & hematology ,urologic and male genital diseases ,medicine.disease ,Primary Neoplasm ,Nephrectomy ,03 medical and health sciences ,Pneumonectomy ,0302 clinical medicine ,medicine.anatomical_structure ,Renal cell carcinoma ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Surgery ,In patient ,Radiology ,business ,Kidney cancer - Abstract
Development of distant metastases from renal cell carcinoma (RCC) is a frequent occurrence and, in nearly 95% of the cases, secondary lesions present within 5 years following nephrectomy. We performed a left pneumonectomy for a peri-hilar lung mass in an 81-year-old man with history of kidney cancer, resected 37 years earlier. Histopathological examination revealed a solitary lung metastasis from RCC, relapsed after an extraordinary 37-year time interval. To the best of our knowledge, this remarkable case represents the longest time interval between radical nephrectomy for RCC and the occurrence of a pulmonary metastasis. After an uneventful post-operative recovery, there are no signs of disease recurrence at a 3-year follow-up. The possibility of a lung metastasis should be taken into account in patients with history of RCC who present with pulmonary nodules, even decades after treatment of the primary neoplasm.
- Published
- 2017
- Full Text
- View/download PDF
34. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer
- Author
-
James Clarke, Pandurangan Vijayanand, Peter S. Friedmann, Edwin Woo, Emma King, Aiman Alzetani, Serena J Chee, Christian H. Ottensmeier, Eva M. Garrido-Martin, Divya Singh, Toby Mellows, Gareth J. Thomas, Oliver Wood, Tilman Sanchez-Elsner, Grégory Seumois, Anusha-Preethi Ganesan, and Daniela Samaniego-Castruita
- Subjects
0301 basic medicine ,medicine.medical_treatment ,Immunology ,T-cell receptor ,hemic and immune systems ,chemical and pharmacologic phenomena ,Immunotherapy ,Biology ,medicine.disease ,Article ,03 medical and health sciences ,CTL ,030104 developmental biology ,Immune system ,Antigen ,medicine ,Immunology and Allergy ,Cytotoxic T cell ,Lung cancer ,Cytotoxicity - Abstract
Therapies that boost the anti-tumor responses of cytotoxic T lymphocytes (CTLs) have shown promise; however, clinical responses to the immunotherapeutic agents currently available vary considerably, and the molecular basis of this is unclear. We performed transcriptomic profiling of tumor-infiltrating CTLs from treatment-naive patients with lung cancer to define the molecular features associated with the robustness of anti-tumor immune responses. We observed considerable heterogeneity in the expression of molecules associated with activation of the T cell antigen receptor (TCR) and of immunological-checkpoint molecules such as 4-1BB, PD-1 and TIM-3. Tumors with a high density of CTLs showed enrichment for transcripts linked to tissue-resident memory cells (TRM cells), such as CD103, and CTLs from CD103(hi) tumors displayed features of enhanced cytotoxicity. A greater density of TRM cells in tumors was predictive of a better survival outcome in lung cancer, and this effect was independent of that conferred by CTL density. Here we define the 'molecular fingerprint' of tumor-infiltrating CTLs and identify potentially new targets for immunotherapy.
- Published
- 2017
35. Giant spontaneous herniation of the post-pneumonectomy cavity
- Author
-
Adnan Raza, Aiman Alzetani, and Alessandro Tamburrini
- Subjects
medicine.medical_specialty ,Lung ,business.industry ,medicine.medical_treatment ,Mediastinal Shift ,Case Report ,Postoperative recovery ,030204 cardiovascular system & hematology ,Surgery ,Polypropylene mesh ,03 medical and health sciences ,Pneumonectomy ,0302 clinical medicine ,medicine.anatomical_structure ,030228 respiratory system ,medicine ,Hernia sac ,Surgical excision ,Intercostal space ,business - Abstract
Following a pneumonectomy, excessive mediastinal shift can cause rare complications involving the post-pneumonectomy cavity, which can become the seat of herniation of the residual lung and of the heart. We herein report an even more rare event, entailing an impressive herniation of the actual entire post-pneumonectomy cavity through an intercostal space, which developed spontaneously nearly 3 years after surgery. Surgical excision of the hernia sac and repair of the defect with polypropylene mesh provided adequate treatment and good cosmetic results. Postoperative recovery was uneventful and no signs of recurrence have been observed.
- Published
- 2017
36. Modified Thoracoplasty Using a Breast Implant to Obliterate an Infected Pleural Space: An Alternative to Traditional Thoracoplasty
- Author
-
Aiman Alzetani, Habib Khan, and Edwin Woo
- Subjects
Adult ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Breast Implants ,Radiography ,law.invention ,Prosthesis Implantation ,law ,Humans ,Medicine ,Right upper lobe ,Thoracoplasty ,Pneumonectomy ,Pleural Cavity ,Rib cage ,business.industry ,Follow up studies ,Prostheses and Implants ,Plastic Surgery Procedures ,medicine.disease ,Empyema ,Surgery ,Treatment Outcome ,Chronic disease ,Empyema, Tuberculous ,Chronic Disease ,Breast implant ,Female ,Radiography, Thoracic ,Pulmonary Aspergillosis ,Lung resection ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Thoracoplasty is a technique used to obliterate residual intrapleural spaces after lung resection for infection or other causes. It involves multiple osteotomies on several ribs and then collapsing them into the space to be obliterated; however, this results in a distorted and asymmetrical chest wall. We report a case of a 34-year-old female with completely destroyed right upper lobe secondary to chronic Aspergillus infection. She underwent a completion right upper lobectomy and modified thoracoplasty with the use of a breast implant to obliterate the residual pleural space without any distortion of the chest wall, with an excellent outcome.
- Published
- 2015
- Full Text
- View/download PDF
37. P079 <break /> Evaluation of romidepsin (FK228) as a potential therapy for idiopathic pulmonary fibrosis (IPF)
- Author
-
Kate O'Reilly, Patricia J. Sime, Sumeet Mahajan, Teresa D. Tetley, Paul Skipp, Donna E. Davies, Aiman Alzetani, Elizabeth R. Davies, Luca Richeldi, Thomas H. Thatcher, Jane Warner, Tom Havelock, David E. Smart, Claire Calderwood, Philip L. Molyneaux, Mark Jones, Benjamin Marshall, Toby M. Maher, and Franco Conforti
- Subjects
medicine.medical_specialty ,Idiopathic pulmonary fibrosis ,business.industry ,Internal medicine ,medicine ,General Medicine ,business ,medicine.disease ,Gastroenterology ,Romidepsin ,medicine.drug - Published
- 2016
- Full Text
- View/download PDF
38. Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker Discovery
- Author
-
Sridhar Rathinam, Jane Starczynski, Ashley Martin, Philip J. Johnson, Wenbin Wei, Nicholas D. James, Aiman Alzetani, Michael J.O. Wakelam, Stephen O Nyangoma, Douglas G. Ward, Lucinda Billingham, and Pala B. Rajesh
- Subjects
Oncology ,medicine.medical_specialty ,Pathology ,Lung ,business.industry ,Clinical Biochemistry ,Confounding ,General Medicine ,Control subjects ,medicine.disease ,Proteomics ,medicine.anatomical_structure ,Serum biomarkers ,Internal medicine ,medicine ,Molecular Medicine ,Biomarker (medicine) ,Non small cell ,Lung cancer ,business ,Molecular Biology - Abstract
IntroductionLung cancer is the leading cause of cancer-related death worldwide. The discovery of new biomarkers could aid early diagnosis and monitoring of recurrence following tumor resection.MethodsWe have prospectively collected serum from 97 lung cancer patients undergoing surgery with curative intent and compared their serum proteomes with those of 100 noncancer controls (59 disease-free and 41 with a range of nonmalignant lung conditions). We initially analyzed serum from 67 lung cancer patients and 73 noncancer control subjects by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry using immobilized metal affinity capture ProteinChip arrays and subsequently validated our findings with an independent analysis of 30 lung cancer patients and 27 noncancer subjects.ResultsThe data from both experiments show many significant differences between the serum proteomes of lung cancer patients and nondiseased control subjects, and a number of these polypeptides have been identified. However, the profiles of patients with benign lung diseases resembled those of lung cancer patients such that very few significant differences were found when these cohorts were compared.ConclusionsThis report provides clear evidence of the need to account for the confounding effects of benign diseases when designing lung cancer serum biomarker discovery projects.
- Published
- 2009
- Full Text
- View/download PDF
39. Endoscopic vein harvesting with the aid of carbon dioxide insufflation
- Author
-
Aiman Alzetani, Sunil K. Ohri, Robert Costa, and Malcolm J.R. Dalrymple-Hay
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Veins ,Long Saphenous Vein ,Vein harvesting ,medicine ,Humans ,Derivation ,Coronary Artery Bypass ,Vein ,Carbon dioxide insufflation ,Endoscopes ,medicine.diagnostic_test ,business.industry ,Insufflation ,Carbon Dioxide ,Surgical Instruments ,Surgery ,Endoscopy ,medicine.anatomical_structure ,Hemostasis ,Tissue and Organ Harvesting ,cardiovascular system ,Cardiology and Cardiovascular Medicine ,business ,Artery - Abstract
Endoscopic harvesting of the long saphenous vein has been introduced to decrease the morbidity of obtaining venous conduit for coronary artery bypass grafting. Herein is described an endoscopic method using carbon dioxide insufflation into the tissues around the vein. This has several advantages; improved vision, no physical retraction required, easier development of tissue planes, and improved hemostasis.
- Published
- 2001
- Full Text
- View/download PDF
40. Ptosis postcardiac surgery: a case of pituitary apoplexy
- Author
-
Robert Costa, Aiman Alzetani, Christopher Fisher, and Sunil K. Ohri
- Subjects
Pulmonary and Respiratory Medicine ,Male ,Reoperation ,medicine.medical_specialty ,Pituitary gland ,Coronary Disease ,Ptosis ,Paralysis ,medicine ,Cranial nerve disease ,Blepharoptosis ,Humans ,Derivation ,Coronary Artery Bypass ,Aged ,business.industry ,Pituitary apoplexy ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,medicine.anatomical_structure ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Complication ,business ,Pituitary Apoplexy ,Artery - Abstract
We present a patient in whom ptosis and third cranial nerve palsy developed postcoronary artery bypass grafting, and discuss the management of pituitary apoplexy postcardiac surgery.
- Published
- 2002
41. THE CARBOMEDICS SUPRA-ANNULAR (TOP HAT) AORTIC VALVE PROSTHESIS: MIDTERM RESULTS AND IMPACT ON PATIENT PROSTHESIS MISMATCH
- Author
-
Timothy R. Graham, Aiman Alzetani, Ian C. Wilson, Steve J Rooney, and Mahmoud Loubani
- Subjects
medicine.medical_specialty ,Aortic valve prosthesis ,business.industry ,medicine.medical_treatment ,Biomedical Engineering ,Biophysics ,Bioengineering ,General Medicine ,Prosthesis ,Biomaterials ,Internal medicine ,medicine ,Cardiology ,business - Published
- 2005
- Full Text
- View/download PDF
42. Does explorative thoracotomy for non-small cell lung cancer (NSCLC) adversely affect patients’ outcome postoperatively?
- Author
-
James Rigby, Adam Lea, Aiman Alzetani, and Shilajit Ghosh
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,non-small cell lung cancer (NSCLC) ,General Medicine ,medicine.disease ,Affect (psychology) ,musculoskeletal system ,Outcome (game theory) ,Surgery ,body regions ,Internal medicine ,medicine ,Thoracotomy ,business - Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.